Previous sessionNext session Therapeutic horizons I Networking zone 1 (N1) In programme Wednesday, 23 October, 2019 - 15:00 to 16:30 View presentations Chair VanderplasschenWouter Ghent UniversityBelgium Keywords Treatment: cognitive-behaviouralOpiatesPsychedelicsTreatment: medical/pharmacologicalNew trendsMental healthE-healthClinical toolsComorbidityProgramme evaluation Presentations Plenary session Poster session Big debate Structured session Workshop Oral presentation session Short communication session Poster guided tour 15:10 Oral presentation A peer-led integrated approach for co-existing mental and addictive disorders: a longitudinal qualitative study of the first UK dual diagnosis anonymous 15:10 to 15:25 Networking zone 1 (N1) Raffaella Margherita Milani 15:25 Oral presentation m-Health among illicit drug users: effectiveness, differential indication, risks and negative effects and ongoing developments among guided and unguided interventions 15:25 to 15:40 Networking zone 1 (N1) Michael Schaub 15:40 Oral presentation Associations of ketamine use with mental health and substance use outcomes at 12 months follow-up in young Europeans 15:40 to 15:55 Networking zone 1 (N1) Meryem Grabski 15:55 Oral presentation The acceptability of psychedelics as treatment options in psychiatry. Data from GDS2019 15:55 to 16:10 Networking zone 1 (N1) Adam Winstock 16:10 Oral presentation Effectiveness and cost-effectiveness of adjunctive personalised psychosocial intervention in treatment-resistant maintenance opioid agonist therapy: a pragmatic, open-label, randomised controlled trial 16:10 to 16:25 Networking zone 1 (N1) John Marsden